GABAPENTIN

Product NDC
71610-757
11-digit product format
716100757
Labeler code
71610
Product ID
71610-757_9f1cfdaf-a07f-4f37-9f9c-695cafe6cfee
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
gabapentin
Dosage form
CAPSULE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA214956
Marketing category
ANDA
Marketing start
2021-05-10
Substance
GABAPENTIN
Active strength
400 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
6CW7F3G59XGABAPENTIN60142-96-3GABAPENTIN

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71610-757-537161007575360 CAPSULE in 1 BOTTLE (71610-757-53) 60 capsule2023-11-28NoNoHistorical
71610-757-607161007576090 CAPSULE in 1 BOTTLE (71610-757-60) 90 capsule2024-01-03NoNoHistorical
71610-757-8071610075780180 CAPSULE in 1 BOTTLE (71610-757-80) 180 capsule2023-11-28NoNoHistorical
71610-757-9471610075794360 CAPSULE in 1 BOTTLE (71610-757-94) 360 capsule2024-01-03NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
GABAPENTINAphena Pharma Solutions - Tennessee, LLC2024-01-04HUMAN PRESCRIPTION DRUG LABEL6